Abstract: Methods and systems for integrating multiple portions of a container are provided. The method and system are specifically designed for integrating multiple shell portions with ear lobe-shaped tabs. The method comprises: providing a first set of retention structures to be associated with a plurality of inter-connecting features formed on an edge of a first shell part, wherein the first set of retention structures comprise at least a lead-in feature and a retention feature; providing a second set of retention structures to be associated with a plurality of inter-connecting features formed on an edge of a second shell part, wherein the second set of retention structures comprise at least a deflection feature and a retention feature; and engaging the two shell parts with aid of the retention structures.

Abstract: The present invention includes methods of identifying a patient who will likely be responsive to treatment with a protein arginine N-methyltransferase 5 inhibitor, or a pharmaceutically acceptable salt thereof, and methods of treating the same.

Abstract: Methods and systems for integrating multiple portions of a container are provided. The method and system are specifically designed for integrating multiple shell portions with ear lobe-shaped tabs. The method comprises: providing a first set of retention structures to be associated with a plurality of inter-connecting features formed on an edge of a first shell part, wherein the first set of retention structures comprise at least a lead-in feature and a retention feature; providing a second set of retention structures to be associated with a plurality of inter-connecting features formed on an edge of a second shell part, wherein the second set of retention structures comprise at least a deflection feature and a retention feature; and engaging the two shell parts with aid of the retention structures.

Abstract: Methods and systems for integrating multiple portions of a container are provided. The method and system are specifically designed for integrating multiple shell portions with ear lobe-shaped tabs. The method comprises: providing a first set of retention structures to be associated with a plurality of inter-connecting features formed on an edge of a first shell part, wherein the first set of retention structures comprise at least a lead-in feature and a retention feature; providing a second set of retention structures to be associated with a plurality of inter-connecting features formed on an edge of a second shell part, wherein the second set of retention structures comprise at least a deflection feature and a retention feature; and engaging the two shell parts with aid of the retention structures.

Abstract: Methods and systems for integrating multiple portions of a container are provided. The method and system are specifically designed for integrating multiple shell portions with ear lobe-shaped tabs. The method comprises: providing a first set of retention structures to be associated with a plurality of inter-connecting features formed on an edge of a first shell part, wherein the first set of retention structures comprise at least a lead-in feature and a retention feature; providing a second set of retention structures to be associated with a plurality of inter-connecting features formed on an edge of a second shell part, wherein the second set of retention structures comprise at least a deflection feature and a retention feature; and engaging the two shell parts with aid of the retention structures.

Abstract: A flexible bulk container includes side walls coupled to a bottom wall. The side walls and the bottom wall generally enclose an interior space that is accessible through a top of the flexible bulk container for loading materials therein. A support structure includes elongate frame elements. Each of the frame elements may be attached to at least one of the side walls and is configured to support the at least one of the side walls generally upright so that the flexible bulk container is maintained in a generally open position. Each of the frame elements may be detachable from the respective at least one of the side walls. The flexible bulk containers and the support structures may be used in a waste management system for loading and sorting of bulk waste materials.

Abstract: The present invention relates to chemical compounds of general formula (I) which may possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders.

Abstract: The present invention relates to chemical compounds of general formula (I) which may possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders.

Abstract: The present invention relates to chemical compounds of general formula (I) which may possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders.

Abstract: A flexible bulk container includes side walls coupled to a bottom wall. The side walls and the bottom wall generally enclose an interior space that is accessible through a top of the flexible bulk container for loading materials therein. A support structure includes elongate frame elements. Each of the frame elements may be attached to at least one of the side walls and is configured to support the at least one of the side walls generally upright so that the flexible bulk container is maintained in a generally open position. Each of the frame elements may be detachable from the respective at least one of the side walls. The flexible bulk containers and the support structures may be used in a waste management system for loading and sorting of bulk waste materials.

Abstract: The present invention relates to benzothiazole compounds that mimic the activity of BH3 only proteins and are capable of binding to and neutralizing pro survival Bcl 2 proteins. The invention also relates to the use of such compounds in the regulation of cell death or cell survival and the treatment and/or prophylaxis of diseases or conditions associated with the deregulation of cell death or cell survival.

Abstract: The present invention relates to chemical compounds of general formula (I) which may possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders.